Device Trial Radar · NCT07745647
Voll Non-Degradable Shoulder Spacer FIH Study
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Sep 2027
Study completion Sep 2028
Sponsor
- Lead sponsor
- Voll Medical Technologies Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 4, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Voll Non-Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a non-degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).
Conditions
- Massive Rotator Cuff Tears
- Massive Rotator Cuff Tear
Interventions
Voll Non-Degradable Shoulder SpacerDevice
Voll Non-Degradable Shoulder Spacer
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device-related Serious Adverse EventsTime frame: Up to 12 months post-implantation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Assuta Ashdod Hospital
Ashdod, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.